APP and Alzheimer disease: Using the APP (amyloid precursor protein) transgenic mouse model of AD, it has been found that the presence of Aβ plaques induced an impairment in GABAergic innervation of the AIS18 and also leads to a reduction in AIS length and βIV-Spectrin expression, which is an essential structural protein of AIS19.